AI-designed minibinders
Custom binders against your target, designed computationally and validated in the lab.
Minibinders are small, AI-designed proteins that bind a target of interest. They are single-chain and carry no disulfide bonds or glycosylation, so they express at high yield in E. coli and are inexpensive to produce, and a binder is distributed as a sequence rather than as a cell line. Their small size gives access to epitopes that are sterically occluded for an antibody, and in preclinical work it translates into deeper tissue and tumor penetration. Reported affinities reach the picomolar range.
Because a minibinder is defined entirely by its sequence, it is straightforward to functionalize. It can be genetically fused to affinity tags, fluorescent proteins, enzymes, Fc domains, or receptor signaling domains, so one validated binder can be moved between an ELISA, an imaging reagent, a biosensor, and a cell-based assay without being re-derived.
We computationally design candidate sequences against your target of choice, using structure-based design models and in silico filtering. Candidates are then expressed and validated experimentally in our lab. Every candidate is measured for stability and affinity, and all candidates that bind the target are also screened for specificity against the relevant off-targets, so that a binder is characterized on all three axes before you build an application on it.
To find the strongest binders, we screen up to millions of minibinder sequences in a single experiment with Transposon Display, our patented screening technology. Screening and optimizing many designs ensures that you find the best binder for your application. It also lets us experimentally validate the computational design workflow and generate large datasets that can be used to optimize the underlying AI models.
The same approach applies to a binder you already have. By mutating all residues across the sequence and screening the resulting library, we identify variants with improved affinity, stability, or specificity, and can adapt an existing binder to a new format or assay condition.
You receive deeply characterized binders optimized for your application of choice. We can develop the assay around them, such as an ELISA, transfer the protocols to your lab, or supply you with the binders long-term.
Typical study designs
- De novo minibinder design against a target of your choice
- Affinity, stability, and specificity characterization of designed candidates
- Large-scale screening of binder libraries with Transposon Display
- Affinity maturation of an existing binder sequence
- Binder customization for a specific application format
- Minibinder-based assay development and long-term binder supply
Let's plan your study
Every study that is executed incorrectly consumes valuable sample material, and, more importantly, wastes time and manpower. In our fast-paced scientific environment, these resources cannot be recovered.